Učitavanje...
DDIS-25. TARGETING GLIOBLASTOMA HETEROGENEITY WITH miR-34a
microRNA-34a could serve as a novel therapeutic agent as it is under-expressed in Glioblastoma and modulates the expression of multiple genes in the deregulated p53, Rb and receptor tyrosine kinase networks which confer selective growth advantage and represent significant intra-tumoral heterogeneity...
Spremljeno u:
| Izdano u: | Neuro Oncol |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216330/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.304 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|